B Round investors are considering investing in TherapeutX using Scenario 1 assumptions.TherapeutX management has approached B Round investors with a plan to delay Exit two years to increase Exit Value from $125 million to $150 million (Scenario 3). The two-year delay would require additional financings resulting in B round investors having a 40% dilution rather than the 30% dilution in Scenario 1. What % ownership would be acceptable to B Round investors under Scenario 3? Would you prefer Scenario 1 or 3? Why?